Sept 11 (Reuters) - Moderna said on Monday it is collaborating with Immatics to develop cancer vaccines.
Immatics will get $120 million upfront cash as part of the agreement. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.02 USD | +1.75% | +2.89% | +4.94% |
Sept 11 (Reuters) - Moderna said on Monday it is collaborating with Immatics to develop cancer vaccines.
Immatics will get $120 million upfront cash as part of the agreement. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
126.1 USD | +7.48% | +3.00% | 44.96B | ||
11.02 USD | +1.75% | +2.89% | 1.12B | ||
1st Jan change | Capi. | |
---|---|---|
+4.94% | 1.12B | |
+5.25% | 109B | |
+11.25% | 105B | |
-0.38% | 22.25B | |
-12.05% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.05% | 16.85B | |
+3.20% | 13.76B | |
+36.73% | 12.46B |